Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 4, 1997, Pages 1235-1240

  Tamaoki, Jun ^a   Kondo, Mitsuko ^b   Sakai, Noritaka ^b   Nakata, Junko ^b   Takemura, Hisashi ^b   Nagai, Atsushi ^b   Takizawa, Takao ^b   Konno, Kimio ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PLACEBO; PRANLUKAST; PROCATEROL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SCREENING; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0030903255     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.4.9105060     Document Type: Article

References (29)

1. British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre. National Asthma Campaign. 1990. Guidelines for the management of asthma in adults: I. Chronic persistent asthma. B.M.J. 301:651-653.
2. International consensus report on the diagnosis and management of asthma. 1992. Clin. Exp. Allergy 22(Suppl.):1-72.
3. Guidelines on the management of asthma. 1993. Thorax 48(Suppl.):S1-S24.
4. Brown, P. H., G. Blundell, A. P. Greening, and G. K. Crompton. 1991. Hypothalamo-pituitary-adrenal axis suppression in asthmatics inhaling high dose corticosteroids. Respir. Med. 85:501-510.
5. Meeran, K., A. Hattersley, J. Burrin, R. Shiner, and K. Ibbertson. 1995. Oral and inhaled corticosteroids reduce bone formation as shown by plasma osteocalcin levels. Am. J. Respir. Crit. Care Med. 151:333-336.
6. Hanania, N. A., K. R. Chapman, W. C. Sturtridge, J. P. Szalai, and S. Kesten. 1995. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosleroids. J. Allergy Clin. Immunol. 96:571-579.
7. Mak, V. H. F., R. Melchor, and S. G. Spiro. 1992. Easy bruising as a side-effect of inhaled corticosteroids. Eur. Respir. J. 5:1068-1074.
8. Connett, G., and W. Lenney. 1991. Inhaled budesonide and behavioural disturbances. Lancet 338:634-635.
9. Kruszynska, Y. T., M. Greenstone, P. D. Home, and N. J. Cooke. 1987. Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax 42:881-884.
10. Taniguchi, Y., G. Tamura, M. Honma, T. Aizawa, N. Maruyama, K. Shirato, and T. Takishima. 1993. The effect of an oral leukotriene antagonist, ONO-1708, on allergen-induced immediate bronchoconstriction in asthmatic subjects. J. Allergy Clin. Immunol. 92:507-512.
11. 4 receptor antagonist, in subjects with bronchial asthma. Am. J. Respir. Crit. Care Med. 150:618-623.
12. Robuschi, M., E. Riva, L. M. Fuccella, E. Vida, R. Barnabe, M. Rossi, G. Gambaro, S. Spagnotto, and S. Bianco. 1992. Prevention of exercise-induced bronchoconstriction by a new leukotriene antagonist (SK&F 104353). Am. Rev. Respir. Dis. 145:1285-1288.
13. 4-receptor antagonist. N. Engl. J. Med. 323:1736-1739.
14. Obata, T., F. Nambu, T. Kitagawa, H. Terashima, M. Toda, T. Okegawa, and A. Kawasaki. 1987. ONO-1708: an antagonist of leukotrienes. Adv. Prostaglandin Thromboxane Leukot. Res. 17:540-543.
15. Ahlstedt, S. 1995. Clinical application of eosinophilic cationic protein in asthma. Allergy Proc. 16:59-62.
16. Kharitonov, S. A., D. Yates, R. A. Robbins, R. Logan-Sinclair, E. A. Shinebourne, and P. J. Barnes. 1994. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-135.
17. Neukirch, F., R. Liard, C. Segala, M. Korobaeff, C. Henry, and J. Cooreman. 1992. Peak expiratory flow variability and bronchial responsiveness to methacholine: an epidemiologic study in 117 workers. Am. Rev. Respir. Dis. 146:71-75.
18. Brand, P. L., D. S. Postma, H. A. Kerstjens, and G. H. Koeter. 1992. Relationship of airway hyperresponsiveness to respiratory symptoms and diurnal peak flow variation in patients with obstructive lung disease. The Dutch CNSLD Study Group. Am. Rev. Respir. Dis. 143:916-921.
19. Haahtela, T., M. Järvinen, T. Kava, K. Kiviranta, S. Koskinen, K. Lehtonen, K. Nikander, T. Persson, O. Selroos, A. Sovijärvi, B. Stenius-Aarniala, T. Svahn, R. Tammivaara, and L. A. Laitinen. 1994. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N. Engl. J. Med. 331:700-705.
20. Spence, D. P. S., S. L. Johnston, P. M. A. Calverley, P. Dhillon, C. Higgins, E. Ramhamadany, S. Turner, A. Winning, J. Winter, and S. T. Holgate. 1994. The effect of the orally active platelet-activating factor antagonist WEB 2086 in the treatment of asthma. Am. J. Respir. Crit. Care Med. 149:1142-1148.
21. Bianco, S., A. Vaghi, M. Robuschi, R. M. Refini, G. M. Pieroni, and P. Sestini. 1995. Steroid-sparing effect of inhaled lysine acetylsalicylate and furosemide in high-dose beclomethasone-dependent asthma. J. Allergy Clin. Immunol. 95:937-943.
22. Sugai, T., Y. Sakiyama, and S. Matsumoto. 1992. Eosinophil cationic proteins in peripheral blood of pediatric patients with allergic diseases. Clin. Exp. Allergy 22:275-281.
23. Kharitonov, S. A., D. H. Yates, and P. J. Barnes. 1996. Inhaled glucocorlicosteroids decrease nitric oxide in exhaled air of asthmatic patients. Am. J. Respir. Crit. Care Med. 153:454-457.
24. 4 effects on human eosinophil and neutrophil motility in vitro. J. Leukoc. Biol. 55:183-191.
25. 4 and granulocytic infiltration into asthmatic airways. Lancet 341:989-990.
26. Wenzel, S. E., J. B. Trudeau, D. A. Kaminsky, J. Cohn, R. J. Martin, and J. Y. Westcott. 1995. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am. J. Respir. Crit. Care Med. 152:897-905.
27. 4, on adult patients with asthma: a double-blind placebo-controlled study. Igaku No Ayami 164:225-247.
28. Mullarkey, M. F., B. A. Blumenstein, P. Andrade, G. A. Bailey, I. Olason, and C. E. Wetzel. 1988. Methotrexate in the treatment of corticosteroid-dependent asthma: a double-blind crossover study. N. Engl. J. Med. 318:603-607.
29. Alexander, A. G., N. C. Barnes, and A. B. Kay. 1992. Trial of cyclosporin in corticosteroid dependent chronic severe asthma. Lancet 339: 324-328.